Why DarioHealth Corp.’s (DRIO) Stock Is Up 8.36%
As of Wednesday, August 19, DarioHealth Corp.’s DRIO share price has surged by 8.36%, which has investors questioning if this is right time to sell.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Commentary & Analysis
Why DarioHealth Corp.’s (DRIO) Stock Is Up 6.15%
As of Thursday, August 13, DarioHealth Corp.’s DRIO share price has surged by 6.15%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why DarioHealth Corp.’s (DRIO) Stock Is Down 6.79%
As of Tuesday, August 11, DarioHealth Corp.’s DRIO share price has dipped by 6.79%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Why DarioHealth Corp.’s (DRIO) Stock Is Down 5.07%
As of Monday, July 27, DarioHealth Corp.’s DRIO share price has dipped by 5.07%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Why DarioHealth Corp.’s (DRIO) Stock Is Up 8.16%
As of Wednesday, July 22, DarioHealth Corp.’s DRIO share price has surged by 8.16%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Financial Summary
| Share Statistics | DRIO | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $70.9 | $200.5 | 18% |
|
| Shares Out (Mil) | 9.3 | 47.8 | 19% |
|
| Institutional Ownership | 19.3% | 79.0% | 10% |
|
| Float (Mil) | 7.7 | 39.8 | 16% |
|
| Beta | 1.12 | 1.17 | 67% |
|
| Avg Daily Volume (000s) | 20 | 331 | 20% |
|
| Price Change (52-week) |
(19.6%) | 44.9% | 30% |
|
| Growth | DRIO | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 24.1% | 11.8% | 85% |
|
| Net Income (5yr) | (7.2%) | 2.7% | 32% |
|
| EPS (5yr) | 38.1% | 15.5% | 87 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.5%) | (15.8%) | 49% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | ($0.510) | ($2.465) | ($1.120) | |
| Month Ago EPS | ($0.625) | ($2.810) | ($0.680) | |
| # Rev Up | 1 | 0 | 1 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.625) | ($2.810) | ($0.680) | |
| Year/Year Chg | (39.9%) | (75.6%) | (99.1%) | |
| Financials | DRIO | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $21 | $202 | 13% |
|
| Net Income (TTM) (Mil) | ($36) | ($9) | 19% |
|
| EPS (TTM) | ($0.947) | ($0.600) | 21% |
|
| Operating Cash Flow (TTM) (Mil) | ($25) | ($1) | 13% |
|
| Net Cash Flow (TTM) (Mil) | na | $3 | na |
|
| Long-Term Debt (Q1) (Mil) | $32 | $18 | 35% |
|
| Enterprise Value (Q1) (Mil) | $93 | $197 | 21% |
|
| Valuation | DRIO | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.96 | 1.38 | 20% |
|
| P/E | na | 39.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 2.4 | na |
|
| Ratios | DRIO | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 61.6% | 61.6% | 74% |
|
| Net Margin | (169.9%) | (24.1%) | 5% |
|
| ROA | (34.8%) | (21.8%) | 15% |
|
| ROE | (59.9%) | (6.7%) | 13% |
|
| Liabilities to Assets | 43.0% | 32.1% | 34% |
|
| F-Score | 2 | 4 | 7% |
|
DarioHealth Corp. did not pass any screens on 8/20/2026.
